http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#head http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#assertion http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#provenance http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#publicationInfo http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#assertion http://bio2rdf.org/drugbank:DB00930 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00930_DB01118 http://bio2rdf.org/drugbank:DB01118 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00930_DB01118 http://bio2rdf.org/drugbank_resource:DB00930_DB01118 http://purl.org/dc/terms/identifier drugbank_resource:DB00930_DB01118 http://bio2rdf.org/drugbank_resource:DB00930_DB01118 http://purl.org/dc/terms/title DDI between Colesevelam and Amiodarone - Bile Acid Sequestrants may decrease the bioavailability of Amiodarone. Consider alternative antilipemic agent. The risk of subtherapeutic amiodarone serum concentrations when such is being used for the treatment of malignant arrhythmias can be very large. The effect (ie, reduced risk) of separating doses of these agents is unknown. Amiodarone should be administered at least 1 hour before or 4 hours after colesevelam.1 Similar dosing with other agents seems warranted. http://bio2rdf.org/drugbank_resource:DB00930_DB01118 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00930_DB01118 http://www.w3.org/2000/01/rdf-schema#label DDI between Colesevelam and Amiodarone - Bile Acid Sequestrants may decrease the bioavailability of Amiodarone. Consider alternative antilipemic agent. The risk of subtherapeutic amiodarone serum concentrations when such is being used for the treatment of malignant arrhythmias can be very large. The effect (ie, reduced risk) of separating doses of these agents is unknown. Amiodarone should be administered at least 1 hour before or 4 hours after colesevelam.1 Similar dosing with other agents seems warranted. [drugbank_resource:DB00930_DB01118] http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#provenance http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#publicationInfo http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#signature.MC4CFQCHao09IN2X http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#signature.MC4CFQCHao09IN2X http://purl.org/nanopub/x/hasSignature MC4CFQCHao09IN2XOzHB+vc0Me0kuLbe7AIVAIvrW7QQ8e3Azjrn5bRWWvD+mRG1 http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#signature.MC4CFQCHao09IN2X http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg http://purl.org/dc/terms/created 2018-03-30T11:13:13.965+02:00 http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg#signature.MC4CFQCHao09IN2X http://bio2rdf.org/drugbank_resource:DB00930_DB01118_nanopub.RAPbu4DlSvc2Yj8WgQ8fpk7anQ4ANeblhxRmrAw6C-TQg http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234